Snibe Shows Great Charms at EuroMedlab 2022 in Munich
Release Date:2022-04-15
EuroMedlab
Munich 2022, the largest exhibition in the field of Clinical Chemistry and
Laboratory Medicine in Europe, which attracted more than 2000 participants, was
held in ICM International Congress Center from April 10 to 14, 2022.
With the 128sqm
spectacular exhibition booth, Snibe brought the latest innovations to the
exhibition, which once again attracted the attention of many visitors.
The most
eye-catching products of the exhibition were undoubtedly one of the highest
space efficiency CLIA analyzers---MAGLUMI? X3. Snibe launched a new CLIA
analyzer MAGLUMI? X3, with high throughput (200 tests/hour) and in a small
footprint (<0.68 m2). All MAGLUMI? reagent kits (181 parameters)
are compatible with MAGLUMI? X3. With the advantage of high space efficiency,
it is more suitable to be installed in different types of laboratories.
During the
exhibition, remarkable reagent menus and typical products including MAGLUMI? 4000
Plus and Biossays? E6 also attracted lots of professional audiences, who showed
their keen interest in the powerful clinical test platform of Snibe and came to
learn details.
Snibe is
proud that more and more hospitals and laboratories are using MAGLUMI CLIA
analyzers, which have performed many studies with the Snibe MAGLUMI CLIA system
apart from routine testing. In this extraordinary meeting, we highly
appreciated that four professors participated in clinical application lectures
and share new insights into immunoassays.
President Elect of the EFLM, Prof. Mario Plebani chaired the educational workshop and delivered a speech
regarding why, when, and how to use SARS-CoV-2 antibodies testing during the
COVID-19 pandemic. He presented the importance of antibody testing in improving
our knowledge of the immune responses to SARS-CoV-2, in seroprevalence surveys,
in clinical treatment, and in monitoring the antibody response to vaccines.
Another Speaker Prof. János Kappelmayer, director
of Laboratory Medicine Dept, University of Debrecen – Hungary, presented their experiences
with AMH and Tacrolimus measurements on the MAGLUMI 800 Analyzer. He stated that
Snibe MAGLUM has a wide test portfolio, and the usage is quite simple with
small sample volume.
On the second day of EuroMedLab, the
educational workshop was chaired by Prof. Tomris Ozben, the president of EFLM
and from the Dept. of Clinical Biochemistry Faculty of Medicine, Akdeniz
University, Turkey. Another Speaker Prof. Tomás Zima is the president of the Czech
Society Clinical Biochemical and from the Faculty of Medicine, Charles
University.
Prof. Tomás Zima delivered a speech
regarding the classification of tumor markers and the characteristics of ideal
tumor markers. He gave the audience a more systematic
understanding of routine tumor markers and the potential value of new markers.
Prof. Tomris Ozben chaired methods to measure tumor
markers and clinical uses of tumor markers for malignant diseases. She indicated that the combination of two or more tumor markers can
increase the diagnostic and prognostic performance in clinical practice.
As a leading brand of Chemiluminescence
Immunoassay solution from China, Snibe has been focusing on CLIA solution for
26 years and has exported its products to more than 146 countries with 19000
units installed.